Naltrexon Vitaflo (Naltrexone Hydrochloride)

Naltrexone works by competitively binding to mu, kappa, and delta opioid receptors without activating them. This blockade prevents both endogenous opioids and external opioid drugs from stimulating the receptors, thereby diminishing the rewarding effects that drive dependence and relapse.

The appropriate dose of Naltrexon Vitaflo is determined by the prescribing clinician based on the individual patient's condition, treatment goals, and medical history. Specific dosing regimens are not provided here and should be obtained from a qualified healthcare professional.

Safety data for Naltrexon Vitaflo in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and this decision must be made in consultation with a qualified healthcare provider.

To order Naltrexon Vitaflo, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams worldwide, and will request verification of trade or institutional credentials before providing pricing, availability, shipping details, and any necessary import documentation.

Compared with alternatives such as acamprosate for alcohol dependence or methadone/buprenorphine for opioid dependence, Naltrexon Vitaflo offers a non‑opioid, antagonist‑based approach that blocks opioid receptors rather than activating them. This can be advantageous for patients seeking abstinence without the risk of additional opioid exposure, though individual response and tolerability vary.

Naltrexon Vitaflo should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in their original packaging, protect them from moisture and direct sunlight, and ensure the container is tightly closed to maintain product stability.

Naltrexon Vitaflo is supplied as oral tablets intended for swallowing whole with water. It is typically taken once daily, although the exact schedule is set by the prescribing clinician based on the therapeutic plan.

The most serious risks include potential liver injury, severe depression, and suicidal thoughts or behaviors. Patients should be monitored regularly for signs of hepatic dysfunction and mood changes, and any concerning symptoms should prompt immediate medical evaluation.

Naltrexon Vitaflo is contraindicated in individuals with acute opioid intoxication, severe hepatic impairment, or known hypersensitivity to naltrexone or any excipients. It should also be used with caution in patients with uncontrolled psychiatric conditions or those currently undergoing opioid withdrawal.